Orthoretroviral-like prototype foamy virus gag-pol expression is compatible with viral replication

Retrovirology

Dirk Lindemann²  Hanswalter Zentgraf¹  Juliane Reh²  Constanze Wiek²  Anka Swiersy² 

[1] Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany;CRTD/DFG-Center for Regenerative Therapies Dresden - Cluster of Excellence, Biotechnology Center, Technische Universität Dresden, Dresden, Germany

关键词: Pol processing;    capsid assembly;    retroviral morphogenesis;    Gag-Pol fusion protein;    Foamy virus;   

Others  :  1209412
DOI  :  10.1186/1742-4690-8-66

 received in 2011-04-06, accepted in 2011-08-15,  发布年份 2011

【 摘 要 】

Background

Foamy viruses (FVs) unlike orthoretroviruses express Pol as a separate precursor protein and not as a Gag-Pol fusion protein. A unique packaging strategy, involving recognition of briding viral RNA by both Pol precursor and Gag as well as potential Gag-Pol protein interactions, ensures Pol particle encapsidation.

Results

Several Prototype FV (PFV) Gag-Pol fusion protein constructs were generated to examine whether PFV replication is compatible with an orthoretroviral-like Pol expression. During their analysis, non-particle-associated secreted Pol precursor protein was discovered in extracellular wild type PFV particle preparations of different origin, copurifying in simple virion enrichment protocols. Different analysis methods suggest that extracellular wild type PFV particles contain predominantly mature p85^PR-RT and p40^IN Pol subunits. Characterization of various PFV Gag-Pol fusion constructs revealed that PFV Pol expression in an orthoretroviral manner is compatible with PFV replication as long as a proteolytic processing between Gag and Pol proteins is possible. PFV Gag-Pol translation by a HIV-1 like ribosomal frameshift signal resulted in production of replication-competent virions, although cell- and particle-associated Pol levels were reduced in comparison to wild type. In-frame fusion of PFV Gag and Pol ORFs led to increased cellular Pol levels, but particle incorporation was only marginally elevated. Unlike that reported for similar orthoretroviral constructs, a full-length in-frame PFV Gag-Pol fusion construct showed wildtype-like particle release and infectivity characteristics. In contrast, in-frame PFV Gag-Pol fusion with C-terminal Gag ORF truncations or non-removable Gag peptide addition to Pol displayed wildtype particle release, but reduced particle infectivity. PFV Gag-Pol precursor fusion proteins with inactivated protease were highly deficient in regular particle release, although coexpression of p71^Gag resulted in a significant copackaging of these proteins.

Conclusions

Non-particle associated PFV Pol appears to be naturally released from infected cells by a yet unknown mechanism. The absence of particle-associated Pol precursor suggests its rapid processing upon particle incorporation. Analysis of different PFV Gag-Pol fusion constructs demonstrates that orthoretroviral-like Pol expression is compatible with FV replication in principal as long as fusion protein processing is possible. Furthermore, unlike orthoretroviruses, PFV particle release and infectivity tolerate larger differences in relative cellular Gag/Pol levels.

【 授权许可】

   
2011 Swiersy et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Rethwilm A: Molecular biology of foamy viruses. Med Microbiol Immunol 2010, 199:197-207.
• [2]Swanstrom R, Wills JW: Synthesis, Assembly, and Processing of Viral Proteins. In Retroviruses. Edited by Coffin JM, Hughes SH. H.E. V. Plainview, NY 11803: Cold Spring Harbor Laboratory Press; 1997:263-334.
• [3]Brierley I, Dos Ramos FJ: Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. Virus Res 2006, 119:29-42.
• [4]Bennett RP, Rhee S, Craven RC, Hunter E, Wills JW: Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. J Virol 1991, 65:272-280.
• [5]Felsenstein KM, Goff SP: Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J Virol 1988, 62:2179-2182.
• [6]Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B: Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 1993, 193:661-671.
• [7]Park J, Morrow CD: Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J Virol 1991, 65:5111-5117.
• [8]Weaver TA, Talbot KJ, Panganiban AT: Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol 1990, 64:2642-2652.
• [9]Buchschacher GL Jr, Yu L, Murai F, Friedmann T, Miyanohara A: Association of murine leukemia virus pol with virions, independent of Gag-Pol expression. J Virol 1999, 73:9632-9637.
• [10]Cen S, Niu M, Saadatmand J, Guo F, Huang Y, Nabel GJ, Kleiman L: Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol. J Virol 2004, 78:1042-1049.
• [11]Linial ML, Eastman SW: Particle assembly and genome packaging. Curr Top Microbiol Immunol 2003, 277:89-110.
• [12]Lee EG, Kuppers D, Horn M, Roy J, May C, Linial ML: A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA. J Virol 2008, 82:1656-1664.
• [13]Peters K, Wiktorowicz T, Heinkelein M, Rethwilm A: RNA and protein requirements for incorporation of the pol protein into foamy virus particles. J Virol 2005, 79:7005-7013.
• [14]Wiktorowicz T, Peters K, Armbruster N, Steinert AF, Rethwilm A: Generation of an improved foamy virus vector by dissection of cis-acting sequences. J Gen Virol 2009, 90:481-487.
• [15]Lee EG, Linial ML: The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions. J Virol 2008, 82:10803-10810.
• [16]Roy J, Linial ML: Role of the foamy virus pol cleavage site in viral replication. J Virol 2007, 81:4956-4962.
• [17]Mergia A, Heinkelein M: Foamy virus vectors. Curr Top Microbiol Immunol 2003, 277:131-159.
• [18]Hartl MJ, Bodem J, Jochheim F, Rethwilm A, Rosch P, Wohrl BM: Regulation of Foamy Virus Protease Activity by Viral RNA - a Novel and Unique Mechanism Among Retroviruses. J Virol 2011.
• [19]Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
• [20]Heinkelein M, Leurs C, Rammling M, Peters K, Hanenberg H, Rethwilm A: Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J Virol 2002, 76:10069-10073.
• [21]Heinkelein M, Thurow J, Dressler M, Imrich H, Neumann-Haefelin D, McClure MO, Rethwilm A: Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging. J Virol 2000, 74:3141-3148.
• [22]Fischer N, Heinkelein M, Lindemann D, Enssle J, Baum C, Werder E, Zentgraf H, Müller JG, Rethwilm A: Foamy virus particle formation. J Virol 1998, 72:1610-1615.
• [23]Konvalinka J, Löchelt M, Zentgraf H, Flügel RM, Kräusslich HG: Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol 1995, 69:7264-7268.
• [24]Bodem J, Löchelt M, Winkler I, Flower RP, Delius H, Flügel RM: Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol 1996, 70:9024-9027.
• [25]Enssle J, Jordan I, Mauer B, Rethwilm A: Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci USA 1996, 93:4137-4141.
• [26]Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML: Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 1996, 271:1579-1582.
• [27]Löchelt M, Flügel RM: The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol 1996, 70:1033-1040.
• [28]Heinkelein M, Dressler M, Jarmy G, Rammling M, Imrich H, Thurow J, Lindemann D, Rethwilm A: Improved primate foamy virus vectors and packaging constructs. J Virol 2002, 76:3774-3783.
• [29]Lee EG, Roy J, Jackson D, Clark P, Boyer PL, Hughes SH, Linial ML: Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation. J Virol 2011, 85:1655-1661.
• [30]Cartellieri M, Herchenröder O, Rudolph W, Heinkelein M, Lindemann D, Zentgraf H, Rethwilm A: N-terminal gag domain required for foamy virus particle assembly and export. J Virol 2005, 79:12464-12476.
• [31]Zemba M, Wilk T, Rutten T, Wagner A, Flügel RM, Löchelt M: The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology 1998, 247:7-13.
• [32]DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP: Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987, 7:379-387.
• [33]Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB: Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 1974, 33:1027-1033.
• [34]Schmidt M, Rethwilm A: Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 1995, 210:167-178.
• [35]Stirnnagel K, Lüftenegger D, Stange A, Swiersy A, Müllers E, Reh J, Stanke N, Grosse A, Chiantia S, Keller H, et al.: Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 2010, 7:45. BioMed Central Full Text
• [36]Dulude D, Baril M, Brakier-Gingras L: Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1. Nucleic Acids Res 2002, 30:5094-5102.
• [37]Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, Thurow J, Knaus P, Zentgraf H, Rethwilm A: A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 2001, 75:5762-5771.
• [38]Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, Bock M, McClure MO, Rethwilm A: Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997, 71:7305-7311.
• [39]Lindemann D, Bock M, Schweizer M, Rethwilm A: Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol 1997, 71:4815-4820.
• [40]Lindemann D, Rethwilm A: Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J Virol 1998, 72:4088-4094.
• [41]Mannigel I, Stange A, Zentgraf H, Lindemann D: Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 2007, 81:3317-3326.
• [42]Imrich H, Heinkelein M, Herchenroder O, Rethwilm A: Primate foamy virus Pol proteins are imported into the nucleus. J Gen Virol 2000, 81:2941-2947.
• [43]Duda A, Stange A, Luftenegger D, Stanke N, Westphal D, Pietschmann T, Eastman SW, Linial ML, Rethwilm A, Lindemann D: Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol 2004, 78:13865-13870.
• [44]Yu SF, Eastman SW, Linial ML: Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 2006, 7:966-977.
• [45]Kräusslich HG, Fäcke M, Heuser AM, Konvalinka J, Zentgraf H: The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol 1995, 69:3407-3419.